Rafi Ahmad

Rafi Ahmad is a Professor at UiT The Arctic University of Norway specializing in Clinical Bioinformatics, based in Tromsø. He leads translational research within the Clinical Bioinformatics Research Group, focusing on accelerating infectious disease diagnostics through novel sequencing technologies to transform clinical decision-making for sepsis and urinary tract infections.

His research centers on antimicrobial resistance (AMR) profiling and rapid pathogen detection using culture-independent methods. Key innovations include nanopore sequencing workflows that reduce diagnostic turnaround times from days to 4-9 hours, enabling real-time treatment adjustments. He investigates microbiome dynamics in inflammatory conditions like ulcerative colitis and develops machine learning-enhanced biosensors (e.g., SERS nanowire chips) for strain-level bacterial identification. His work bridges clinical microbiology, bioinformatics, and One Health frameworks to address AMR globally.

Analysis of his 2022-2025 publications reveals a consistent trajectory toward point-of-care diagnostic implementation, with emphasis on urine, blood, and tissue samples. Methodologies prioritize speed (<4-hour workflows), cost-effectiveness, and compatibility with clinical settings. Recent studies integrate multi-omics approaches (metagenomics, transcriptomics) with AI for resistance prediction, highlighting translational impact across human, animal, and environmental health domains.

As an active member of the Clinical Bioinformatics Research Group (MH øst L9.105B), he collaborates internationally on projects like AMR-Educate, focusing on technology transfer from research to clinical practice. His lab specializes in optimizing sequencing protocols for real-world use, including sample preparation enhancements that bypass culture steps.